Alpha Profiles · Company Profile

Damora Therapeutics, Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/damora-therapeutics-inc

Entity: Public listing published
Primary listing: NASDAQ: DMRA
Verification: Partially verified
Last reviewed: 2026-09-13T04:45:57.604557+00:00

Overview

Alpha's canonical identity and public leadership record for Damora Therapeutics, Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

5 public records

Becker Hewes

Chief Medical Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-191429Apr 29, 2026

Garrett Winslow

General Counsel

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-191429Apr 29, 2026

Jennifer Jarrett

President and Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-191429Apr 29, 2026

Lori Firmani

Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-191429Apr 29, 2026

Sherwin Sattarzadeh

Chief Operating Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-191429Apr 29, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 13, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.